Maurice Perol

17PUBLICATIONS
120CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 09, 2025
Unresectable stage III non-small-cell lung cancer: state of the art and challenges.

Jordi Remon, Antonin Levy, Romane Gille

|Aug 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study).

Renaud Descourt, Florian Guisier, Maurice Pérol

|Apr 03, 2025
Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUST.

Maurice Pérol, Wei Li, Nathan A Pennell

|Jan 06, 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.

Jacob Sands, Myung-Ju Ahn, Aaron Lisberg

Pageof 3